- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
- 10-K Annual report
- 10.44 Services Agreement
- 21.1 List of Subsidiaries
- 23.1 Consent of KPMG LLP
- 23.2 Consent of Pricewaterhousecoopers, LLP
- 31.1 Certification of CEO Pursuant to Section 302
- 31.2 Certification of CFO Pursuant to Section 302
- 32.1 Certification of CEO Pursuant to Section 906
- 99.1 Biomarin/genzyme LLC, Financial Statements
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors
BioMarin Pharmaceutical Inc.:
We consent to the incorporation by reference in (i) the registration statements (Nos. 333-84787 and 333-85368) on Form S-8 and (ii) the registration statements (Nos. 333-116575, 333-102066 and 333-108972) on Form S-3 of BioMarin Pharmaceutical Inc. of our reports dated March 7, 2006, with respect to the consolidated balance sheets of BioMarin Pharmaceutical Inc. as of December 31, 2005 and 2004, and the related consolidated statements of operations, changes in stockholders’ equity (deficit), and cash flows for each of the years in the three-year period ended December 31, 2005, and the related financial statement schedule, management’s assessment of the effectiveness of internal control over financial reporting as of December 31, 2005, and the effectiveness of internal control over financial reporting as of December 31, 2005, which reports appear in the December 31, 2005, annual report on Form 10-K of BioMarin Pharmaceutical Inc.
Our reports were based on our audits and the report of other auditors.
/s/ KPMG LLP
San Francisco, California
March 7, 2006